Seeking Alpha

TearLab slides after reporting wider-than-expected loss

  • Shares of TearLab (TEAR) sink 9% AH as the company reports a Q2 loss that is three times wider than analysts expected.
  • Results were impacted to the tune of -$0.26 by "the revaluation of warrants issued in June 2011 and annual options that were granted and fully vested in Q2."
  • It's worth noting that while revenues rose 392% Y/Y, cost of good sold jumped 524% from Q2 2012. Sales and marketing expenses rose 268%. (PR)
  • Total Osmolarity systems booked for Q2: 569.
  • Cash and equivalents as of June 30 of $7.2M. This obviously doesn't include the $37.5M TEAR raised in a public offering on July 25.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|